Interdepartmental Division of Critical Care Medicine at University of Toronto, Toronto, ON, Canada.
Department of Medicine, University of Toronto, Toronto, ON, Canada.
Crit Care Med. 2021 Jan 1;49(1):19-26. doi: 10.1097/CCM.0000000000004698.
To evaluate long-term uptake of an antimicrobial stewardship audit-and-feedback program along with potential predictors of stewardship suggestions and acceptance across a diverse ICU population.
A retrospective cohort study.
An urban, academic medical institution.
Patients admitted to an ICU who received an antimicrobial stewardship program suggestion between June 2010 and September 2019.
None.
The antimicrobial stewardship program provided 7,749 antibiotic assessments over the study period and made a suggestion to alter therapy in 2,826 (36%). Factors associated with a higher likelihood of receiving a suggestion to alter therapy included shorter hospital length of stay prior to antimicrobial stewardship program review (odds ratio 1.15 for ≤ 5 d; 95% CI 1.00-1.32), admission to cardiovascular (1.37; 1.06-1.76) or burn surgery (1.88; 1.50-2.36) versus general medicine, and preceding duration of antibiotic use greater than 5 days (1.33; 1.10-1.60). Assessment of aminoglycosides (2.91; 1.85-4.89), carbapenems (1.93; 1.54-2.41), and vancomycin (2.71; 2.19-3.36) versus ceftriaxone was more likely to result in suggestions to alter therapy. The suggestion acceptance rate was 67% (1,895/2,826), which was stable throughout the study period. Admission to a level 3 ICU was associated with higher likelihood of acceptance of suggestions (1.50; 1.14-1.97). Factors associated with lower acceptance rates were admission to burn surgery (0.64; 0.45-0.91), treatment of pneumonia (0.64; 0.42-0.97 for community-acquired and 0.65; 0.44-0.94 for ventilator-acquired), unknown source of infection (0.66; 0.48-0.92), and suggestion types of "narrow spectrum" (0.65; 0.45-0.94), "change formulation of antibiotic" (0.42; 0.27-0.64), or "change agent of therapy" (0.63; 0.40-0.97) versus "change of dose".
An antimicrobial stewardship program implemented over a decade resulted in sustained suggestion and acceptance rates. These findings support the need for a persistent presence of audit-and-feedback over time with more frequent suggestions to alter potentially nephrotoxic agents, increased efforts toward specialized care units, and further work approaching infectious sources that are typically treated without pathogen confirmation and identification.
评估一项抗菌药物管理审核与反馈计划的长期应用情况,以及该计划在不同 ICU 患者人群中提出建议和被接受的潜在预测因素。
回顾性队列研究。
城市学术医疗中心。
2010 年 6 月至 2019 年 9 月期间入住 ICU 并接受抗菌药物管理计划建议的患者。
无。
在研究期间,抗菌药物管理计划共进行了 7749 次抗生素评估,并提出了 2826 次(36%)改变治疗方案的建议。更有可能收到改变治疗方案建议的因素包括抗菌药物管理计划审查前住院时间较短(≤5 天的比值比 1.15;95%CI 1.00-1.32)、心血管(1.37;1.06-1.76)或烧伤外科(1.88;1.50-2.36)而非普通内科(1.00),以及抗菌药物使用时间超过 5 天(1.33;1.10-1.60)。氨基糖苷类(2.91;1.85-4.89)、碳青霉烯类(1.93;1.54-2.41)和万古霉素(2.71;2.19-3.36)的评估比头孢曲松更有可能导致改变治疗方案的建议。建议接受率为 67%(1895/2826),在整个研究期间保持稳定。入住 3 级 ICU 与更高的建议接受率相关(1.50;1.14-1.97)。较低的接受率与烧伤外科治疗(0.64;0.45-0.91)、肺炎治疗(社区获得性肺炎为 0.64;0.42-0.97,呼吸机相关性肺炎为 0.65;0.44-0.94)、未知感染源(0.66;0.48-0.92)以及建议类型为“窄谱”(0.65;0.45-0.94)、“改变抗生素剂型”(0.42;0.27-0.64)或“改变治疗药物”(0.63;0.40-0.97)而非“改变剂量”相关(0.63;0.40-0.97)。
实施了十多年的抗菌药物管理计划产生了持续的建议和接受率。这些发现支持在一段时间内持续存在审核与反馈的必要性,更频繁地建议改变可能具有肾毒性的药物,加强对专科护理病房的努力,并进一步处理通常未经病原体确认和鉴定就进行治疗的感染源。